10/17
08:27 am
artv
Rating for ARTV
Medium
Report
Rating for ARTV
10/17
08:27 am
artv
Rating for ARTV
Medium
Report
Rating for ARTV
10/17
08:12 am
artv
Artiva Biotherapeutics (NASDAQ:ARTV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics (NASDAQ:ARTV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
10/17
06:33 am
artv
Rating for ARTV
High
Report
Rating for ARTV
10/17
06:33 am
artv
Rating for ARTV
High
Report
Rating for ARTV